LIVING CELL TECHNOLOGIES LIMITED (ASX:LCT)
Industry: Pharmaceuticals, Biotechnology and Life Sciences
Activity: Living Cell Technologies: developing cell-based therapies for type 1 diabetes and neurological disorders.
70 Pitt Street Suite 302 Level 3 SYDNEY NSW 2000
Ph: 1300 134 875    Fax: (02) 9233 4497
David Brookes
Mon, 24 May 2010 1:30pm
*ASX takes no responsibility for the information included in this presentation. Participation in this event should not be taken as an endorsement by ASX of the company.
Mr Paul Tan
Thu, 31 Jul 2008 12:30pm
Cell Therapy to Generate New Functioning Tissue
Dr Robert Caspari
Thu, 31 Jul 2008 10:30am
LCT Appoints New CEO
Icon_lastIcon_nextIcon_previousIcon_first

Executives & Directors

Chairman, Independent Director
Executive Director
Independent Director
Independent Director
Independent Director
Secretary
Please contact the ASX to change these details

Company Podcasts

Interim Results
Tue, 28 Feb 2012
Full Year Results
Thu, 25 Aug 2011
EGM
Tue, 7 Jun 2011
Interim Results
Fri, 25 Feb 2011
Annual General Meeting
Thu, 18 Nov 2010
Annual General Meeting
Thu, 19 Nov 2009 1:00pm
Full Year Results
Mon, 19 Oct 2009 1:00am
Interim Results
Fri, 27 Feb 2009
Annual General Meeting
Thu, 6 Nov 2008 1:30pm
Annual General Meeting
Wed, 28 Nov 2007
LCT`s DIABECELL trial extension approved Thu, 17 May 2012
Change of Director`s Interest Notice Fri, 4 May 2012
Appendix 3B Thu, 3 May 2012
Cleansing Statement Thu, 3 May 2012
LCT`s Share Purchase Plan successful Tue, 1 May 2012
Appendix 4C - quarterly Mon, 30 Apr 2012
Dr Barry Snow to lead Parkinson`s trial for LCT Tue, 17 Apr 2012
Share Purchase Plan documents mailed to Shareholders Fri, 30 Mar 2012
LCT Presents Novel Parkinson`s Disease Treatment Results Wed, 21 Mar 2012
LCT announces Share Purchase Plan Tue, 20 Mar 2012

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. BRR Media does not claim any association with any company listed on this site.